These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23526658)

  • 1. Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies.
    Wallace SJ; Nation RL; Li J; Boyd BJ
    J Pharm Sci; 2013 May; 102(5):1578-87. PubMed ID: 23526658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.
    Wallace SJ; Li J; Nation RL; Prankerd RJ; Boyd BJ
    J Pharm Sci; 2012 Sep; 101(9):3347-59. PubMed ID: 22623044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.
    Mangal S; Xu R; Park H; Zemlyanov D; Shetty N; Lin YW; Morton D; Chan HK; Li J; Zhou QT
    Pharm Res; 2018 Nov; 36(1):6. PubMed ID: 30406281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface Composition and Aerosolization Stability of an Inhalable Combinational Powder Formulation Spray Dried Using a Three-Fluid Nozzle.
    Shetty N; Zhang Y; Park H; Zemlyanov D; Shah D; He A; Ahn P; Mutukuri TT; Chan HK; Zhou QT
    Pharm Res; 2020 Oct; 37(11):219. PubMed ID: 33037471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.
    Wallace SJ; Li J; Nation RL; Prankerd RJ; Velkov T; Boyd BJ
    J Phys Chem B; 2010 Apr; 114(14):4836-40. PubMed ID: 20302384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics.
    Amrol D
    Int J Nanomedicine; 2007; 2(1):9-12. PubMed ID: 17722506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.
    Oh YK; Nix DE; Straubinger RM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin-entrapped liposomes driven by the electrostatic interaction: Mechanism of drug loading and in vivo characterization.
    Li Y; Tang C; Zhang E; Yang L
    Int J Pharm; 2016 Dec; 515(1-2):20-29. PubMed ID: 27713028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation stability and temperature-dependent release kinetics from hydrogel-immobilised liposomes.
    Ullrich M; Hanuš J; Dohnal J; Štěpánek F
    J Colloid Interface Sci; 2013 Mar; 394():380-5. PubMed ID: 23276685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of lung targeting azithromycin liposomes and its tissue distribution in mice].
    Wang JS; Zhu JB; Lu RQ; Shen W
    Yao Xue Xue Bao; 2005 Mar; 40(3):274-8. PubMed ID: 15952603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
    Wollstadt A; Krämer I; Kamin W
    Pharmazie; 2013 Sep; 68(9):744-8. PubMed ID: 24147342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].
    López-Fabal F; Culebras E; Bonilla I; Gómez M; Picazo JJ
    Rev Esp Quimioter; 2008 Sep; 21(3):189-93. PubMed ID: 18792821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of floating drug delivery system of azithromycin.
    Wasnik S; Parmar P; Singh D; Ram A
    Acta Pol Pharm; 2012; 69(3):515-22. PubMed ID: 22594266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2009 May; 35(5):583-93. PubMed ID: 19031311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
    Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB
    J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as carriers of macrolides: preferential association of erythromycin A and azithromycin with liposomes of phosphatidylglycerol containing unsaturated fatty acid(s).
    Stuhne-Sekalec L; Stanacev NZ; Djokic S
    J Microencapsul; 1991; 8(2):171-83. PubMed ID: 1662717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and advantages of furazolidone in liposomal drug delivery systems.
    Alam MI; Paget T; Elkordy AA
    Eur J Pharm Sci; 2016 Mar; 84():139-45. PubMed ID: 26796143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High azithromycin loading powders for inhalation and their in vivo evaluation in rats.
    Zhang Y; Wang X; Lin X; Liu X; Tian B; Tang X
    Int J Pharm; 2010 Aug; 395(1-2):205-14. PubMed ID: 20595022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preparation method and cholesterol on drug encapsulation studies by phospholipid liposomes.
    Cagdas FM; Ertugral N; Bucak S; Atay NZ
    Pharm Dev Technol; 2011 Aug; 16(4):408-14. PubMed ID: 20433249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
    Changsan N; Chan HK; Separovic F; Srichana T
    J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.